Predictors for cardiovascular morbidity and overall mortality in Tunisian ESRD patients: A six year prospective study

Clinical Biochemistry

Volumn 42, Issue 7-8, 2009, Pages 648-653

  Fellah, Hayet ^a   Hammami, Mohamed Bassem ^a   Feki, Moncef ^a   Boubaker, Karima ^b   Abdallah, Taieb Ben ^b   Lacour, Bernard ^c   Mebazaa, Abderraouf ^a   Kaabachi, Neziha ^a  

^a LA RABTA HOSPITAL   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cardiovascular disease; Chronic renal failure; Hemodialysis; Mortality; Renal transplantation; Risk factor

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; PARATHYROID HORMONE;

ACUTE HEART FAILURE; ADOLESCENT; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CLAUDICATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; STROKE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALBUMINS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; FEMALE; HEMOGLOBINS; HOMOCYSTEINE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TUNISIA; YOUNG ADULT;

EID: 63649100582     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.023     Document Type: Article

References (35)

1. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J kidney Dis 32 (1998) 112-119
2. Gupta R., Birnbaum Y., and Uretsky B.F. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol 44 (2004) 1343-1353
3. USRDS: the United States Renal data System. USRDS 2003 annual data report. Am. J. Kidney Dis. 42 (2003) 1-230
4. Cheung A.K., Sarnak M.J., Yan G., et al., HEMO Study Group. Cardiac diseases in maintenance haemodialysis patients: results of the HEMO Study. Kidney Int. 65 (2004) 2380-2389
5. Stenvinkel P., Heimburger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 55 (1999) 1899-1911
6. Eikelboom J.W., and Hankey G.J. Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease. Curr. Opin. Nephrol. Hypertens 10 (2001) 377-383
7. Mallamaci F., Zoccali C., Tripepi G., et al. Hyperhomocysteinemia predicts cardiovascular outcomes in haemodialysis patients. Kidney Int. 61 (2002) 609-614
8. Longenecker J.C., Coresh J., Powe N.R., et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J. Am. Soc. Nephrol. 13 (2002) 1918-1927
9. Avram M.M., Blaustein D., Fein P.A., Goel N., Chattopadhyay J., and Mittman N. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin. Kidney Int. 87 (2003) S6-S11
10. Zoccali C., Mallamaci F., and Tripepi G. Novel cardiovascular risk factors in end stage renal disease. J. Am. Soc. Nephrol. 15 (2004) S77-S80
11. Suliman M., Stenvinkel P., Qureshi A.R., et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol. Dial. Transplant. 22 (2007) 209-217
12. Portolés J., López-Gómez J.M., and Aljama P. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Nephrol. Dial. Transplant. 22 (2007) 500-507
13. Fellah H., Feki M., Hsairi M., et al. Hyperhomocysteinemia and ESRD: determinants and association with cardiovascular disease in Tunisian patients. Clin. Chem. Lab. Med. 41 (2003) 675-680
14. Fellah H., Feki M., Feki H., et al. Classical and non classical cardiovascular risk factors in Tunisian patients with end-stage renal disease: prevalence and association with cardio vascular events. Clin. Lab. 5 (2004) 447-453
15. Combe C., Chauveau P., Laville M., et al. French Study Group for Nutrition in Dialysis. Influence of nutritional factors and haemodialysis adequacy on the survival of 1,610 French patients. Am. J. Kidney Dis. 37 (2001) S81-S88
16. Menon V., Greene T., Wang X., et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 68 (2005) 766-772
17. Honda H., Qureshi A.R., Heimbürger O., et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am. J. Kidney Dis. 47 (2006) 139-148
18. Kaysen G.A. Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish. Nephrol. Dial. Transplant. 15 (2000) 1521-1524
19. Yeun J.Y., Levine R.A., Mantadilok V., and Kaysen G.A. C-reactive protein predicts all-cause and cardiovascular mortality in haemodialysis patients. Am. J. Kidney Dis. 35 (2000) 469-476
20. Leon J.B., Majerle A.D., Soinski J.A., Kushner I., Ohri-Vachaspati P., and Sehgal A.R. Can a nutrition intervention improve albumin levels among haemodialysis patients? A pilot study. J. Renal Nutr. 11 (2001) 9-15
21. Owen W.F., and Lowrie E.G. C-reactive protein as an outcome predictor for maintenance haemodialysis patients. Kidney Int. 54 (1998) 627-636
22. Wang A.Y., Woo J., Lam C.W., et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?. J. Am. Soc. Nephrol. 14 (2003) 1871-1879
23. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for health-care professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
24. Stefenelli T., Abela C., Frank H., et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for followup. J. Clin. Endocrinol. Metab. 82 (1997) 106-112
25. Strozecki P., Adamowicz A., Nartowicz E., Odrowaz-Sypniewska G., Wlodarczyk Z., and Manitius J. Parathormone, calcium, phosphorus, and left ventricular structure and function in normotensive haemodialysis patients. Ren. Fail. 23 (2001) 115-126
26. Akizawa T., Kinugasa E., Kurihara S., et al. Parathyroid hormone deficiency is an indicator of poor nutritional state and prognosis in dialysis patients. J. Am. Soc. Nephrol. 10 (1999) 615 A
27. Chertow G.M., Lazarus J.M., Lew N.L., and Lowrie E.G. Intact parathyroid hormone is directly related to mortality in haemodialysis. J. Am. Soc. Nephrol. 11 (2000) 573A (abstract)
28. Avram M.M., Mittman N., Myint M.M., and Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in haemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am. J. Kidney Dis. 38 (2001) 1351-1357
29. Kalantar-Zadeh K., Block G., Humphreys M.H., McAllister C.J., and Kopple J.D. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in haemodialysis patients. J. Am. Soc. Nephrol. 15 (2004) 442-453
30. Liu Y., Coresh J., Eustace J.A., et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291 (2004) 451-459
31. Kopple J.D. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am. J. Clin. Nutr. 81 (2005) 1257-1266
32. Ducloux D., Klein A., Kazory A., Devillard N., and Chalopin J.M. Impact of malnutrition-inflammation on the association between homocysteine and mortality. Kidney Int. 69 (2006) 331-335
33. Silva R.P., Barbosa P.H., Kimura O.S., et al. Prevalence of anaemia and its association with cardio-renal syndrome. Int. J. Cardiol. 120 (2007) 232-236
34. Borrows R., Loucaidou M., and Chusney G. Anaemia and congestive heart failure early post-renal transplantation. Nephrol Dial Transplant 23 (2008) 1728-1734
35. Orth S.R., and Hallan S.I. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients-absence of evidence or evidence of absence?. Clin. J. Am. Soc. Nephrol. 3 (2008) 226-236